ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

Alessandro Brunelli(Marche Polytechnic University), Anne Charloux(Ospedali Riuniti Umberto I), Chris T. Bolliger(Stellenbosch University), Gaetano Rocco(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Sculier Jp(Université Libre de Bruxelles), Gonzálo Varela(Complejo Hospitalario de Salamanca), Marc Licker(University of Geneva), Mark K. Ferguson(University of Chicago), Corinne Faivre‐Finn(Royal Brompton & Harefield NHS Foundation Trust), R. Huber(Ospedali Riuniti Umberto I), Enrico Clini(University of Modena and Reggio Emilia), Thida Win(Lister Hospital), Dirk De Ruysscher(Maastricht University), L Goldman(Columbia University)
European Respiratory Journal
June 30, 2009
Cited by 923Open Access
Full Text

Abstract

A collaboration of multidisciplinary experts on the functional evaluation of lung cancer patients has been facilitated by the European Respiratory Society (ERS) and the European Society of Thoracic Surgery (ESTS), in order to draw up recommendations and provide clinicians with clear, up-to-date guidelines on fitness for surgery and chemo-radiotherapy. The subject was divided into different topics, which were then assigned to at least two experts. The authors searched the literature according to their own strategies, with no central literature review being performed. The draft reports written by the experts on each topic were reviewed, discussed and voted on by the entire expert panel. The evidence supporting each recommendation was summarised, and graded as described by the Scottish Intercollegiate Guidelines Network Grading Review Group. Clinical practice guidelines were generated and finalized in a functional algorithm for risk stratification of the lung resection candidates, emphasising cardiological evaluation, forced expiratory volume in 1 s, systematic carbon monoxide lung diffusion capacity and exercise testing. Contrary to lung resection, for which the scientific evidences are more robust, we were unable to recommend any specific test, cut-off value, or algorithm before chemo-radiotherapy due to the lack of data. We recommend that lung cancer patients should be managed in specialised settings by multidisciplinary teams.


Related Papers

No related papers found

Powered by citation graph analysis